Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, suppress glucagon https://marcjglk810540.wikipublicity.com/7924581/emerging_therapies_for_type_2_diabetes